Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, Procedure Conducted & ASP by Product, Indication & End-User The global electrophysiology devices market will witness a robust CAGR of 10.8%, valued at $6.2 billion in 2021, expected to appreciate and reach $15.60 billion by 2030, confirms Strategic Market Research. Electrophysiology is the test to help physicians understand the nature of abnormal heart rhythm and access electrical heart activity to diagnose arrhythmia or irregular heartbeats. The procedure is done by inserting the catheter with a wire electrode, which measures the electrical activity through blood vessels entering the heart. The Electrophysiology devices are ablation catheters a 3D mapping system, a radiofrequency generator, and access devices available in the electrophysiology laboratories, cardiac centers, and hospitals. Cardiac ablation is one of the most widely used procedures for treating atrial fibrillation. In accordance with the European Society of Cardiology, Sudden Cardiac Arrest is due to abnormal heart rhythm and one of the primary reasons for death in western countries, affecting approximately 1 in 1000 inhabitants per year. The electrophysiology devices market growth is driven by the increase in the prevalence of cardiac arrhythmia, the increase in the number of cardiac ablation procedures, and technological advancements in the manufacturing of electrophysiology devices. Key Market Drivers - Increase in the Prevalence of Cardiac Arrhythmia and Technological Advancements to Manufacture Electrophysiology Devices An increase in the number of diseases such as atrial fibrillation and cardiovascular illnesses is fuelling the electrophysiology industry's growth. Johnson & Johnson reported in 2021 that atrial fibrillation affects approximately 7 million, 14 million, and 20 million people in the U.S, Europe, and Asia-Pacific, respectively. Furthermore, according to the American Medical Association (AMA), cardiovascular disease affects more than half of the adult population in the US. The rise in the geriatric population with chronic diseases is the primary driver of industry growth. As per the CDC, 1 in 6 deaths from cardiovascular diseases is from a sudden heart stroke, and about 60 percent of the people hospitalized are older than 65 years. This will increase in the further years, which will lead to a rise in the demand for electrophysiology. Technological advancements in the medical devices segment like Implantable Cardioverter defibrillators, single- and multiunit extracellular recording, lipid bilayer recording, transepithelial recording, current-clamp recording, voltage-clamp recording, and calculating impedance measurements are expected to provide lucrative opportunities for market expansion. Due to the rise in the growth of electrophysiology catheters, drug discovery, electrophysiology ablation, and catheter-based electrophysiology, the market for electrophysiology is also expected to rise significantly. Restraints - High Cost of Electrophysiology Products The electrophysiology devices market is highly competitive in terms of pricing. The products, within cardiac electrophysiology, are mostly premium, with 3D mapping systems and E.P. recording systems with a price range from USD 250,000 to 800,000. Due to the high capital, training, and maintenance costs, E.P. procedures are generally expensive, which is restraining the industry growth. Opportunities - Increase in the Number of Emerging Industries The emerging markets are expected to offer significant growth opportunities for electrophysiology vendors. This is due to the increase in patient population, increasing disposable incomes, improving healthcare infrastructure, and comparatively permissive restrictions as compared to developed countries. The emerging economies registered a steady increase in surgical procedures over the last decade, owing to a growing target patient population, rising CVD-related deaths, and increasing medical tourism. As per the report of WHO India 2020, 7% of deaths were attributed to CVDs, and 45% of deaths were between 40 and 69 years. Easing regulations and implementation of government initiatives and policies like reimbursement, insurance plans, etc., can reduce the burden on the individuals suffering from diseases and hence are expected to create ample growth opportunities for the market. Electrophysiology Devices Market Analysis Of Different Segments Covered in the Report Based on Product EP Ablation Catheters Cryoablation EP catheters Radiofrequency Ablation Catheters Irrigated-Tip Radiofrequency Ablation Catheters Conventional Radiofrequency Catheter Ablation Microwave Ablation Systems Laser Ablation Systems Navigational Advanced Mapping Accessories EP Laboratory Devices EP X-Ray Systems Electrophysiology 3D Mapping Systems EP Recording Systems EP Remote Steering Systems EP Remote Steering Systems Others EP Diagnostic Catheters Conventional EP Diagnostic Catheters Steerable Diagnostic Catheters Fixed Diagnostic Catheters Advanced EP Diagnostic Catheters Ultrasound EP Diagnostic Catheters Access Devices Others Based on Indication Atrial Fibrillation (AF) Atrial Flutter Atrial tachycardia Supraventricular tachycardia Wolff-Parkinson-White Syndrome (WPW) Atrioventricular Nodal Reentry Tachycardia (AVNRT) Ventricular fibrillation Ventricular tachycardia Others Based on End-User Hospitals & Cardiac Centers Ambulatory Surgery Centers Others Regional Coverage Analysis North America U.S. Mexico Canada Rest of North America Europe France Germany U.K Spain Italy Rest of Europe Asia Pacific China India South Korea Japan Australia Rest of APAC LAMEA Brazil Saudi Arabia Uruguay Argentina Rest of LAMEA Segments Analysis & Insights Based on Product, the EP Ablation Catheters segment dominated the market with a 46% share in 2020. According to a research study published in ESC Heart Failure Journal in September 2020, between 1st January 2020 and 24th March 2020, a total of 269 arrhythmia patients hospitalized for catheter ablation under strict risk assessments and careful infection prevention were retrospectively analyzed and considered for analysis at the center. This is attributed to the increasing use of ablation procedures for treating atrial fibrillation. Based on Indication, the Atrial Fibrillation segment dominated the entire market with 48% of the total share in 2020. This is due to the prevalence of atrial fibrillation, the expanding no of ablation procedures owing to atrial fibrillation, and advanced cardiac mapping systems for the early diagnosis of atrial fibrillation, which is propelling the growth of the segment. Based on End Users, the Hospitals & Cardiac Centers segment dominated the industry with a 90% share in 2020 due to the factors such as a rising prevalence of CVDs, and the presence of electrophysiology labs in hospitals. As per the study published by the National Library of Medicine, daily short-term rhythm strip recordings identified an increase of 13.0% in the elderly population hospitalized for atrial fibrillation. The increased number of ablation procedures and the emergence of advanced electrophysiology products are driving the segment's overall growth. Based on Region, North America possessed the largest electrophysiology devices market share with a steady CAGR in 2020. It can primarily be attributed to the presence of well-established healthcare facilities, a rise in the number of arrhythmia and heart failure cases, and technological advancements in the region. As per the research published in the International Journal of Stroke in January 2020, around 6–12 million population will suffer from atrial fibrillation in the US by 2050. Electrophysiology Devices Market Report Coverage Report Attribute Details Forecast Period 2021-2030 The market size value in 2021 $6.2 Billion The revenue forecast in 2030 $15.60 Billion Growth rate 10.8% The base year for estimation 2021 Historical data 2017 - 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation Based on Product, Based on Indication, Based on End-User, and Based on Regions By Product EP Ablation Catheters(Cry ablation EP catheters, Radiofrequency Ablation Catheters, Irrigated-Tip Radiofrequency Ablation Catheters, Conventional Radiofrequency Catheter Ablation, Microwave Ablation Systems, Laser Ablation Systems, Navigational Advanced Mapping Accessories) EP X-Ray Systems(Electrophysiology 3D Mapping Systems, EP Recording Systems, EP Remote Steering Systems, EP Remote Steering Systems, Others) EP Diagnostic Catheters(Conventional EP Diagnostic Catheters, Steerable Diagnostic Catheters, Fixed Diagnostic Catheters, Advanced EP Diagnostic Catheters, Ultrasound EP Diagnostic Catheters, Access Devices) By Indication Atrial Fibrillation (AF), Atrial Flutter, Atrial tachycardia, Supraventricular tachycardia, Wolff-Parkinson-White Syndrome (WPW), Atrioventricular Nodal Reentry Tachycardia (AVNRT), Ventricular fibrillation, Ventricular tachycardia Based on End-User Hospitals & Cardiac Centers, Ambulatory Surgery Centers By Region U.S, Mexico, Canada, and the Rest of North America Country Scope U.S., Canada, France, Germany, the U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E., etc. Company Usability Profiles Abbott Laboratories,Biotronik SE & Co. KG,Boston Scientific Corporation,CardioFocus, Inc,GE electrophysiology (Healthcare),Koninklijke Philips N.V.,Johnson & Johnson, Inc,Medtronic Plc.,MicroPort Scientific Corporation,Siemens Healthineers AG,Stereotaxis, Inc.,AtriCure, Inc.,AngioDynamics,Biosense Webster Electrophysiology Devices Market Competitive Landscape Analysis The competitive landscape analysis provides crucial information about the competitors prevailing in the global environment. The comparison is performed based on key development strategies, mergers, and acquisitions, new product launches, overall revenue generation, market initiatives, production sites, facilities, market potential, etc. Abbott Laboratories Biotronik SE & Co. KG Boston Scientific Corporation CardioFocus, Inc. GE electrophysiology (Healthcare) Koninklijke Philips N.V. Johnson & Johnson, Inc. Medtronic Plc. MicroPort Scientific Corporation Siemens Healthineers AG Stereotaxis, Inc. AtriCure, Inc. AngioDynamics Biosense Webster Recent Developments On July 2022, X-Trodes, an Israeli start-up announced that it is planning to redefine the process of electro-physiology monitoring. X-Trodes has framed some brand new wireless-wearable technologies for monitoring the eye movement (electro-oculography/EOG), brain activities (electro-encephalography/EEG), muscle stimulation (electro-myography/EMG), & cardiac monitoring (electrocardiogram/ECG). This technology operates in a very similar manner to that of flexible smart skin, by sticking to a certain area of the body like that of a bandage. Abbott's EnSite X EP System with the EnSite Omnipolar Technology (OT), a new cardiac mapping platform available in the US and Europe, is designed to help physicians treat abnormal heart rhythms better and received FDA clearance in 2022. Boston Scientific Corporation has agreed to buy Baylis Medical Company Inc. for $1.75 billion in October 2021, expanding its electrophysiology and structural heart product portfolios to include the radiofrequency NRG and VersaCross Transseptal Platforms. These platforms have advanced transseptal puncture and have been clinically proven to improve safety, efficiency, and efficacy in delivering therapies to the left side of the heart. In October 2020, Johnson & Johnson Medical Devices Company (Biosense Webster) received U.S. Food and Drug Administration (FDA) approval for the THERMO COOL SMART TOUCH SF Ablation Catheter. It is used to treat persistent atrial fibrillation, which improves the quality of life and significantly reduces healthcare resource utilization post-ablation. In December 2020, Acutus announced the launch of the AcQBlate Force Sensing Ablation System in Europe. The AcQBlate is designed with a commercially available gold-tipped, irrigated, force-sensing radiofrequency ablation catheter used for electrophysiology mapping and RF ablation. In November 2020, Japan Lifeline Co. Ltd collaborated with Baylis Medical, a leading company in the commercialization and development of innovative medical devices. They collaborated to introduce advanced electrophysiology procedures in Europe, which allowed the company to expand its business in European countries. Various Leading Electrophysiology Devices that Key Market Leaders Develop Name of the product Function Key Players Multielectrode arrays Records the field potential electrical activity from the electrically active cells such as neurons. Automate scientific,Eurofins Patch-clamp system It is used to study ionic currents in individual isolated living cells, tissue sections, or patches of the cell membranes. AutoMate Scientific, Fluxion Biosciences, HEKA, Nanion Technologies, NeoBiosystems, Inc., Scientifica Electroencephalograms (EEGs) To record the electrical activity of the brain via electrodes affixed to the scalp. NeuroScan, EGI Emotiv, NeuroSky. Electrocardiograms (ECGs), Registers the electrical signals in the heart to detect heart problems and monitor the heart's health. Cardioline, GE Healthcare, and Mindray. Frequently Asked Question About This Report How big is the electrophysiology devices market? The global electrophysiology devices market size was $6.2 Billion in 2021 and is predicted to reach $15.60 Billion by 2030 with a CAGR of 10.8%. What is the electrophysiology devices market growth? The global electrophysiology devices market is expected to grow at a compound annual growth rate (CAGR) of 10.8% from 2021 to 2030 to reach $15.60 Billion by 2030. What are the critical market trends? An increase in the no of cases of cardiac arrhythmia and technological advancements in the manufacturing of electrophysiology devices are the key electrophysiology market trends. What are the critical factors that are expected to limit the growth of the market? High cost of electrophysiology products is one of the major factors limiting the growth of the market. Sources https://www.cdc.gov/heartdisease/facts.htm https://www.who.int/india/health-topics/cardiovascular-diseases https://pubmed.ncbi.nlm.nih.gov/31955707/ https://onlinelibrary.wiley.com/doi/10.1002/joa3.12669 https://www.heart.org/en/news/2019/01/31/cardiovascular-diseases-affect-nearly-half-of-american-adults-statistics-show https://www.cdc.gov/stroke/data-research/facts-stats/index.html https://www.who.int/india/health-topics/cardiovascular-diseases https://pubmed.ncbi.nlm.nih.gov/32940415/ https://pubmed.ncbi.nlm.nih.gov/28883032/ https://pubmed.ncbi.nlm.nih.gov/31955707/ https://www.jnjmedtech.com/en-IN/news-events/atrial-fibrillation-projected-affect-72-million-people-asia-pacific-2050-according-new https://www.jnj.com/media-center/press-releases/biosense-webster-presents-late-breaking-data-from-inspire-and-admire-clinical-trials-at-af-symposium https://www.jnj.com/media-center/press-releases/biosense-webster-supports-collaborative-studies-that-aim-to-expand-knowledge-in-pulsed-field-ablation 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Electrophysiology Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Electrophysiology Market 4.2.1 Global market, 2021 – 2030 (USD Million) 4.3 Regional Analysis 4.3.1 market, by region, 2021-2030 (USD Million) 4.4 By Product Analysis 4.4.1 market, By Product, 2021-2030 (USD Million) 4.5 By End-User Analysis 4.5.1 market, By End-User, 2021-2030 (USD Million) 4.6 Indication Analysis 4.6.1 market, By Indication, 2021-2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 market PEST analysis 4.9.2 market Porter’s analysis 4.10 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Indication Analysis 5.11.1. Trends in Indication (2014-2020) 5.11.2. Trends in Indication (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers, Area Served, Product Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. EP Ablation Catheters 7.3.1. EP Ablation Catheters market, 2021-2030 (USD Million) 7.3.1.1 Cryoablation EP catheters market, 2021-2030 (USD Million) 7.3.1.2 Radiofrequency Ablation Catheters market, 2021-2030 (USD Million) 7.3.1.3 Irrigated-Tip Radiofrequency Ablation Catheters market, 2021-2030 (USD Million) 7.3.1.4 Conventional Radiofrequency Catheter Ablation market, 2021-2030 (USD Million) 7.3.1.1 Microwave Ablation Systems market, 2021-2030 (USD Million) 7.3.1.1 Laser Ablation Systems market, 2021-2030 (USD Million) 7.3.1.1 Navigational Advanced Mapping Accessories market, 2021-2030 (USD Million) 7.4. EP Laboratory Devices 7.4.1 EP Laboratory Devices market, 2021-2030 (USD Million) 7.4.1.1 EP X-Ray Systems market, 2021-2030 (USD Million) 7.4.1.2 Electrophysiology 3D Mapping Systems market, 2021-2030 (USD Million) 7.4.1.3 EP Recording Systems market, 2021-2030 (USD Million) 7.4.1.4 EP Remote Steering Systems market, 2021-2030 (USD Million) 7.4.1.4 EP Remote Steering Systems market, 2021-2030 (USD Million) 7.4.1.4 Others market, 2021-2030 (USD Million) 7.5. EP Diagnostic Catheters 7.5.1. EP Diagnostic Catheters market, 2021-2030 (USD Million) 7.5.1.1 Conventional EP Diagnostic Catheters market, 2021-2030 (USD Million) 7.5.1.2 Steerable Diagnostic Catheters market, 2021-2030 (USD Million) 7.5.1.3 Fixed Diagnostic Catheters market, 2021-2030 (USD Million) 7.5.1.4 Advanced EP Diagnostic Catheters market, 2021-2030 (USD Million) 7.5.1.6 Ultrasound EP Diagnostic Catheters market, 2021-2030 (USD Million) 7.5.1.7 Access Devices market, 2021-2030 (USD Million) 7.5.1.8 Others market, 2021-2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals & Cardiac Centers 8.3.1. Hospitals & Cardiac Centers market, 2021-2030 (USD Million) 8.4. Ambulatory Surgery Centers 8.4.1. Ambulatory Surgery Centers Market, 2021-2030 (USD Million) 8.5. Others 8.5.1. Others market, 2021-2030 (USD Million) 9. Global Market: By Indication Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Atrial Fibrillation (AF) 9.3.1. Atrial Fibrillation (AF) Market, 2021-2030 (USD Million) 9.4. Atrial Flutter 9.4.1. Atrial Flutter Market, 2021-2030 (USD Million) 9.5. Atrial tachycardia 9.5.1. Atrial tachycardia Market, 2021-2030 (USD Million) 9.6. Supraventricular tachycardia 9.5.1. Supraventricular tachycardia Market, 2021-2030 (USD Million) 9.7. Wolff-Parkinson-White Syndrome (WPW) 9.5.1. Wolff-Parkinson-White Syndrome (WPW) Market, 2021-2030 (USD Million) 9.6. Atrioventricular Nodal Reentry Tachycardia (AVNRT) 9.5.1. Atrioventricular Nodal Reentry Tachycardia (AVNRT) Market, 2021-2030 (USD Million) 9.6. Ventricular fibrillation 9.5.1. Ventricular fibrillation Market, 2021-2030 (USD Million) 9.6. Ventricular tachycardia 9.5.1. Ventricular tachycardia Market, 2021-2030 (USD Million) 9.6. Others 9.5.1. Others Market, 2021-2030 (USD Million) 10. Global Market: Regional Outlook 10.1 North America 10.1.1. North American market, by By Product, 2021-2030 (USD Million) 10.1.2. North American market, by By End-User, 2021-2030 (USD Million) 10.1.3. North American market, by Indication, 2021-2030 (USD Million) 10.1.4. North American market, by Country, 2021-2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. market, by By Product, 2021-2030 (USD Million) 10.1.4.1.2. U.S. market, by By End-User, 2021-2030 (USD Million) 10.1.4.1.3. U.S. market, by Indication, 2021-2030 (USD Million) 10.1.4.2. Canada 10.1.4.2.1. Canada market, by By Product, 2021-2030 (USD Million) 10.1.4.2.2. Canada market, by By End-User, 2021-2030 (USD Million) 10.1.4.2.3. Canada market, by Indication, 2021-2030 (USD Million) 10.2. Europe 10.2.1. European market, by By Product, 2021-2030 (USD Million) 10.2.2. European market, by By End-User, 2021-2030 (USD Million) 10.2.3. European market, by Indication, 2021-2030 (USD Million) 10.2.4. European market, by country, 2021-2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. market, by By Product, 2021-2030 (USD Million) 10.2.4.1.2. U.K. market, by By End-User, 2021-2030 (USD Million) 10.2.4.1.3. U.K. market, by Indication, 2021-2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany market, by By Product, 2021-2030 (USD Million) 10.2.4.2.2. Germany market, by By End-User, 2021-2030 (USD Million) 10.2.4.2.3. Germany market, by Indication, 2021-2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France market, by By Product, 2021-2030 (USD Million) 10.2.4.3.2. France market, by By End-User, 2021-2030 (USD Million) 10.2.4.3.3. France market, by Indication, 2021-2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of European market, by By Product, 2021-2030 (USD Million) 10.2.4.4.2. Rest of European market, by By End-User, 2021-2030 (USD Million) 10.2.4.4.3. Rest of European market, by Indication, 2021-2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific market, by By Product, 2021-2030 (USD Million) 10.3.2. Asia Pacific market, by By End-User, 2021-2030 (USD Million) 10.3.3. Asia Pacific market, by Indication, 2021-2030 (USD Million) 10.3.4. Asia Pacific market, by country, 2021-2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China market, by By Product, 2021-2030 (USD Million) 10.3.4.1.2. China market, by By End-User, 2021-2030 (USD Million) 10.3.4.1.3. China market, by Indication, 2021-2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India market, by By Product, 2021-2030 (USD Million) 10.3.4.2.2. India market, by By End-User, 2021-2030 (USD Million) 10.3.4.2.3. India market, by Indication, 2021-2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan market, by By Product, 2021-2030 (USD Million) 10.3.4.3.2. Japan market, by By End-User, 2021-2030 (USD Million) 10.3.4.3.3. Japan market, by Indication, 2021-2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea market, by By Product, 2021-2030 (USD Million) 10.3.4.4.2. South Korea market, by By End-User, 2021-2030 (USD Million) 10.3.4.4.3. South Korea market, by Indication, 2021-2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC market, by By Product, 2021-2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC market, by By End-User, 2021-2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC market, by Indication, 2021-2030 (USD Million) 10.4. Latin America 10.4.1. Latin America market, by By Product, 2021-2030 (USD Million) 10.4.2. Latin America market, by By End-User, 2021-2030 (USD Million) 10.4.3. Latin America market, by Indication, 2021-2030 (USD Million) 10.4.4. Latin America market, by country, 2021-2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil market, by By Product, 2021-2030 (USD Million) 10.4.4.1.2. Brazil market, by By End-User, 2021-2030 (USD Million) 10.4.4.1.3. Brazil market, by Indication, 2021-2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico market, by By Product, 2021-2030 (USD Million) 10.4.4.2.2. Mexico market, by By End-User, 2021-2030 (USD Million) 10.4.4.2.3. Mexico market, by Indication, 2021-2030 (USD Million) 10.4.4.3. Rest of Latin America 10.4.4.3.1. Rest of the Latin America market, by By Product, 2021-2030 (USD Million) 10.4.4.3.2. Rest of the Latin America market, by By End-User, 2021-2030 (USD Million) 10.4.4.3.3. Rest of the Latin America market, by Indication, 2021-2030 (USD Million) 10.5. MEA 10.5.1. MEA market, by By Product, 2021-2030 (USD Million) 10.5.2. MEA market, by By End-User, 2021-2030 (USD Million) 10.5.3. MEA market, by Indication, 2021-2030 (USD Million) 10.5.4. MEA market, by Region, 2021-2030 (USD Million) 11. Competitive Landscape 11.1 Abbott Laboratories 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. Product Portfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2 Biotronik SE & Co. KG 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. Boston Scientific Corporation 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. CardioFocus, Inc 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. GE electrophysiology (Healthcare) 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Koninklijke Philips N.V. . 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. Johnson & Johnson, Inc 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. Medtronic Plc 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. MicroPort Scientific Corporation 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. Siemens Healthineers AG 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development 11.11. Stereotaxis, Inc 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Business Strategy & Recent Development 11.12. AtriCure, Inc 11.12.1. Company overview 11.12.2. Financial performance 11.12.3. Product Portfolio Analysis 11.12.4. Business Strategy & Recent Development 11.13. AngioDynamics 11.13.1. Company overview 11.13.2. Financial performance 11.13.3. Product Portfolio Analysis 11.13.4. Business Strategy & Recent Development 11.14. Biosense Webster 11.14.1. Company overview 11.14.2. Financial performance 11.14.3. Product Portfolio Analysis 11.14.4. Business Strategy & Recent Development List of Tables (57 Tables) TABLE 1. MARKET, By Product, 2021-2030 (USD Million) TABLE 2. MARKET FOR EP Ablation Catheters, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR EP Laboratory Devices, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR EP Diagnostic Catheters, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET, By End-User, 2021-2030 (USD Million) TABLE 6. MARKET FOR Hospitals & Cardiac Centers, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR Ambulatory Surgery Centers, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET, BY INDICATION, 2021-2030 (USD Million) TABLE 11. MARKET FOR Atrial Fibrillation (AF), BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Atrial Flutter, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Atrial tachycardia, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET FOR Supraventricular tachycardia, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Wolff-Parkinson-White Syndrome (WPW), BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Atrioventricular Nodal Reentry Tachycardia (AVNRT), BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Ventricular fibrillation, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Ventricular tachycardia, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 17. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 18. NORTH AMERICA MARKET, By Product, 2021-2030 (USD Million) TABLE 19. NORTH AMERICA MARKET, By End-User, 2021-2030 (USD Million) TABLE 20. NORTH AMERICA MARKET, BY INDICATION, 2021-2030 (USD Million) TABLE 21. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 22. EUROPE MARKET, By Product, 2021-2030 (USD Million) TABLE 23. EUROPE MARKET, By End-User, 2021-2030 (USD Million) TABLE 24. EUROPE MARKET, BY INDICATION, 2021-2030 (USD Million) TABLE 25. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 26. ASIA-PACIFIC MARKET, By Product, 2021-2030 (USD Million) TABLE 27. ASIA-PACIFIC MARKET, By End-User, 2021-2030 (USD Million) TABLE 28. ASIA-PACIFIC MARKET, BY INDICATION, 2021-2030 (USD Million) TABLE 29. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 30. LAMEA MARKET, By Product, 2021-2030 (USD Million) TABLE 31. LAMEA MARKET, By End-User, 2021-2030 (USD Million) TABLE 33. LAMEA MARKET, BY INDICATION, 2021-2030 (USD Million) TABLE 34. Abbott Laboratories: COMPANY SNAPSHOT TABLE 35. Abbott Laboratories: OPERATING SEGMENTS TABLE 36. Biotronik SE & Co. KG: COMPANY SNAPSHOT TABLE 37. Biotronik SE & Co. KG: OPERATING SEGMENTS TABLE 38. Boston Scientific Corporation: COMPANY SNAPSHOT TABLE 39. Boston Scientific Corporation: OPERATING SEGMENTS TABLE 40. CardioFocus, Inc: COMPANY SNAPSHOT TABLE 41. CardioFocus, Inc: OPERATING SEGMENTS TABLE 42. GE electrophysiology (Healthcare): COMPANY SNAPSHOT TABLE 43. GE electrophysiology (Healthcare): OPERATING SEGMENTS TABLE 44. Koninklijke Philips N.V.: COMPANY SNAPSHOT TABLE 45. Koninklijke Philips N.V.: OPERATING SEGMENTS TABLE 46. Johnson & Johnson, Inc: COMPANY SNAPSHOT TABLE 47. Johnson & Johnson, Inc: OPERATING SEGMENTS TABLE 48. Medtronic Plc.: COMPANY SNAPSHOT TABLE 49. Medtronic Plc.: OPERATING SEGMENTS TABLE 50. MicroPort Scientific Corporation: COMPANY SNAPSHOT TABLE 51. MicroPort Scientific Corporation: OPERATING SEGMENTS TABLE 52. Siemens Healthineers AG: COMPANY SNAPSHOT TABLE 53. Siemens Healthineers AG: OPERATING SEGMENTS TABLE 54. Stereotaxis, Inc: COMPANY SNAPSHOT TABLE 55. Stereotaxis, Inc: OPERATING SEGMENTS TABLE 56. AtriCure, Inc: COMPANY SNAPSHOT TABLE 57. AtriCure, Inc: OPERATING SEGMENTS TABLE 56. AngioDynamics: COMPANY SNAPSHOT TABLE 57. AngioDynamics: OPERATING SEGMENTS TABLE 56. Biosense Webster: COMPANY SNAPSHOT TABLE 57. Biosense Webster: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 14 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Electrophysiology, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Electrophysiology, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Indication, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 EP Ablation Catheters to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 16 Atrial Fibrillation (AF) to Witness Higher CAGR in Market for Indication Segment during Forecast Period. Figure 17 Hospitals & Cardiac Centers to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 18 North America region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview